Your session is about to expire
← Back to Search
Cannabinoid
CBD for Youth Alcoholism
Phase 2
Recruiting
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 16 to 22
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes 3 hours after administration of 600mg cbd vs. placebo
Awards & highlights
Study Summary
This trialaims to test CBD as a potential medication to treat alcohol use disorder in young people (ages 16-22). Subjects will receive CBD or placebo, then be assessed over one month.
Who is the study for?
This trial is for young people aged 16-22, whether they drink alcohol or not. It's designed to see if CBD can help with youth alcohol use disorder. Participants will be involved in the study for about a month.Check my eligibility
What is being tested?
The study tests the effects of cannabidiol (CBD) on youth with alcohol use issues using a double-blind method where neither researchers nor participants know who gets CBD or placebo during parts of the trial.See study design
What are the potential side effects?
While not explicitly listed here, common side effects of CBD may include tiredness, diarrhea, changes in appetite/weight. However, each individual might experience different reactions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 16 and 22 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ changes 3 hours after administration of 600mg cbd vs. placebo
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes 3 hours after administration of 600mg cbd vs. placebo
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Alcohol cue reactivity (lab-based paradigm)
Alcohol cue reactivity neural activation
GABA
+1 moreSide effects data
From 2022 Phase 2 & 3 trial • 90 Patients • NCT0438761738%
Tiredness
24%
Drowsiness
24%
Poor sleep
22%
Constipation
18%
Poor Appetite
16%
Dizziness
9%
Headache
7%
Diarrhea
7%
Nausea
4%
Itching
100%
80%
60%
40%
20%
0%
Study treatment Arm
CBD Oil Group
Control Group
Trial Design
2Treatment groups
Experimental Treatment
Group I: Placebo, Then CannabidiolExperimental Treatment1 Intervention
Group II: Cannabidiol, Then PlaceboExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabidiol
FDA approved
Find a Location
Who is running the clinical trial?
Medical University of South CarolinaLead Sponsor
933 Previous Clinical Trials
7,394,585 Total Patients Enrolled
46 Trials studying Alcoholism
5,055 Patients Enrolled for Alcoholism
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 16 and 22 years old.You are a drinker or a non-drinker of alcohol.
Research Study Groups:
This trial has the following groups:- Group 1: Cannabidiol, Then Placebo
- Group 2: Placebo, Then Cannabidiol
Awards:
This trial has 3 awards, including:- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are middle-aged adults admissible to this research?
"This study's age bracket is from 16 to 22 years old."
Answered by AI
What is the FDA's official stance on Cannabidiol?
"Cannabidiol has been evaluated for safety in a Phase 2 trial, meaning that while there is some data to support its safety, there is none yet to support efficacy."
Answered by AI
How many people can join this clinical trial at most?
"Correct. The study, which is looking for 35 patients at a single site, was originally posted on October 1st, 2020 and last updated on November 10th, 2020 according to clinicaltrials.gov."
Answered by AI
Are subjects being recruited for this experiment right now?
"That is correct, the clinical trial posted on October 1st, 2020 is still recruiting patients. The study will take place at a single location and needs 35 participants in total."
Answered by AI
Who might be a candidate for this clinical research?
"This clinical trial is for individuals with alcohol use disorder who are between the ages of 16 and 22. Up to 35 participants will be selected for the study."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger